HEM Pharma's largest shareholder Yoseb Ji reports minor conversion of stock options into common shares by related party - total stake unchanged at 26.65%
The largest shareholder Yoseb Ji and 15 special relations continue to hold 1,957,862 shares, representing 26.65% of total shares outstanding, unchanged from the previous report.
Special relation Park So-young exercised stock options for 9,960 common shares, converting them from options into common equity. Total outstanding shares increased to 7,219,147, but the group's ownership percentage remained the same.
The exercise price was 10,000 KRW per share, generating 99,600,000 KRW in cash for the company, funded through earned income.
The filer maintains the purpose of influencing management as the largest shareholder, with 10 major agreements signed on May 31, 2024 for joint ownership purposes.
[AI Summary]This report reflects a routine conversion of stock options into shares with negligible dilution impact. The change does not materially affect the company's financial position or control structure, and the market impact is neutral.